Want to see JP:2931 full AI Analyst Report?
euglena Co., Ltd. (2931) Stock Price & Analysis
2931 Stock Chart & Stats
- Day’s Range
- JPY 321.00 - JPY 331.00
- 52-Week Range
- JPY 318.00 - JPY 459.00
- Previous Close
- JPY 327.00
- Volume
- 629.20K
- Average Volume (3M)
- 629.54K
- Market Cap
- JPY 44.92B
- Enterprise Value
- JPY 51.31B
- Total Cash (Recent Filing)
- JPY 17.17B
- Total Debt (Recent Filing)
- JPY 23.06B
- Price to Earnings (P/E)
- ―
- Beta
- 0.47
- Next Earnings
- Nov 13, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Dec 29, 2025
- Dividend Yield
- 0.62%
Bulls Say, Bears Say
Bulls Say
Revenue Expansion
The substantial multi-year increase in revenue indicates that Euglena has expanded its commercial reach and product sales base. Continued top-line growth can support operating leverage, broaden the company’s market position, and provide a larger platform for scaling microalgae-derived consumer and industrial applications.
High Gross Margins
Persistently high gross margins suggest that Euglena’s products and ingredients retain meaningful value after direct costs. Margin stability provides resilience for funding marketing and research, while also creating potential for stronger earnings conversion as operating scale improves over the next several quarters.
Improving Operating Profit And Cash Flow
The combination of an operating profit turnaround and materially stronger free cash flow shows improving financial execution. Greater internally generated cash can reduce reliance on external funding, support product development and commercialization, and strengthen the company’s ability to sustain growth investments.
Bears Say
Persistent Net Losses
Despite operating improvements, Euglena has not yet established consistent bottom-line profitability. Ongoing net losses limit retained earnings, reduce financial flexibility, and indicate that operating gains are still being absorbed by other costs before they can produce dependable shareholder returns.
Higher Absolute Debt
Lower relative leverage is encouraging, but rising absolute debt remains a structural constraint on capital allocation. More debt can increase repayment and financing obligations, leaving less flexibility to fund research, commercialization, or growth initiatives if earnings improvement slows.
Modest And Volatile Cash Conversion
Recent cash generation has improved, yet operating cash flow remains modest relative to revenue and has been uneven across the historical period. This suggests that reported sales and operating progress may not consistently translate into cash, complicating investment planning and debt management.
euglena Co., Ltd. News
Euglena Delivers Record FY2025 Results and Announces 20th Anniversary Special Dividend
euglena Co., Ltd. ( ($JP:2931) ) just unveiled an announcement. Euglena Co., Ltd., a Prime Market-listed healthcare player, has been reshaping its profit structure while deepening its focus on direct-to-consumer
2931 FAQ
What was euglena Co., Ltd.’s price range in the past 12 months?
What is euglena Co., Ltd.’s market cap?
When is euglena Co., Ltd.’s upcoming earnings report date?
How were euglena Co., Ltd.’s earnings last quarter?
Is euglena Co., Ltd. overvalued?
Does euglena Co., Ltd. pay dividends?
What is euglena Co., Ltd.’s EPS estimate?
How many shares outstanding does euglena Co., Ltd. have?
What happened to euglena Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of euglena Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
euglena Co., Ltd.
Euglena Co., Ltd. is a Japanese enterprise specializing in the research, development, cultivation, and marketing of microalgae. Its operations are structured around two primary divisions: Healthcare Business and Energy/Environment Business. The company manufactures and sells a variety of euglena-derived food items and cosmetics. Additionally, it offers a broad portfolio of consumer goods, such as health foods, beverages, confectionery, and sports nutrition products. Furthermore, Euglena is engaged in pioneering biofuel and environmental technologies leveraging microalgae, and it makes strategic investments in the biotechnology sector. Its merchandise is distributed through numerous retail channels, including convenience stores, pharmacies, grocery stores, beauty parlors, and various specialty retailers. The company was established in Tokyo, Japan, in 2005.
- Sector
- Consumerdefensive
- Industry
- Household & Personal Products
- CEO
- Tomohiro Wakahara
- Employees
- 793
- Website
- www.euglena.jp
- Address
- G-BASE Tamachi, Tokyo, TY, 108-0014, JP
euglena Co., Ltd. (2931) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |








